Application 020886
- Type
- NDA
- Sponsor
- CONCORDIA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PANRETIN | ALITRETINOIN | GEL;TOPICAL | EQ 0.1% BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020886-001 | PANRETIN | ALITRETINOIN | EQ 0.1% BASE | GEL / TOPICAL | RLD, RS | 1999-02-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020886-001 | PANRETIN | EQ 0.1% BASE | GEL / TOPICAL | RLD, RS | 1999-02-02 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N020886-001 | PANRETIN | EQ 0.1% BASE | GEL / TOPICAL | RLD, RS | 1999-02-02 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N020886-001 | PANRETIN | EQ 0.1% BASE | GEL / TOPICAL | RLD, RS | 1999-02-02 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020886-001 | PANRETIN | EQ 0.1% BASE | GEL / TOPICAL | RLD, RS | 1999-02-02 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020886-001 | PANRETIN | EQ 0.1% BASE | GEL / TOPICAL | RLD, RS | 1999-02-02 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PANRETIN | ALITRETINOIN | Advanz Pharma (US) Corp. | 49c16717-7d86-4257-80c9-baa1417e5555 | 2025-11-25 | Warnings, Adverse reactions | 020886 NDA020886 59212-601 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 59212-601 | PANRETIN | alitretinoin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-601 | PANRETIN | alitretinoin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-601 | PANRETIN | alitretinoin | Concordia Pharmaceuticals Inc. | NDA | Current |
| 62856-601 | Panretin | Alitretinoin | Eisai Inc. | NDA | Current |
| 62856-601 | Panretin | Alitretinoin | Eisai Inc. | NDA | Current |